dc.contributor.author | Yu, Yanlei | |
dc.contributor.author | Hirakane, Makoto | |
dc.contributor.author | Mori, Daisuke | |
dc.contributor.author | Lin, Lei | |
dc.contributor.author | Zhang, Fuming | |
dc.contributor.author | Zhang, Hong | |
dc.contributor.author | Linhardt, Robert J. | |
dc.date | 2017 | |
dc.date.accessioned | 2022-06-27T16:01:10Z | |
dc.date.available | 2022-06-27T16:01:10Z | |
dc.date.issued | 2017-08-01 | |
dc.identifier.citation | Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins, Y. Yu, M. Hirakane, D. Mori, L. Lin, F. Zhang, H. Zhang, R. J. Linhardt, Glycoconjugate Journal, 34, 545–552, 2017. | |
dc.identifier.issn | 15734986 | |
dc.identifier.issn | 2820080 | |
dc.identifier.uri | https://doi.org/10.1007/s10719-017-9774-7 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13015/5618 | |
dc.description | Glycoconjugate Journal, 34, 545–552 | |
dc.description | Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform. | |
dc.description.abstract | Heparin is a structurally complex polysaccharide used as a clinical anticoagulant. It is comprised of a heterogeneous mixture of polysaccharide chains having a variety of sequences and lengths. The production methods and regulatory controls of pharmaceutical heparins have changed over the years. This study assesses the structural and activity uniformity of the polysaccharide chains comprising two contemporary heparin products. The heparin fractions with different sizes and charges were separated with size exclusion and ion exchange chromatography. The fractions were analyzed for their molecular weight properties, di- and tetrasaccharide compositions, and anti-factor IIa and anti-factor-Xa activities. The distribution of these properties through chains of different lengths and ones with different charge density were compared. The results demonstrate that with the increase in heparin purity, activity and molecular weight required by the current pharmacopeia, the uniformity of pharmaceutical heparin products have increased. | |
dc.description.sponsorship | National Institutes of Health | |
dc.description.uri | https://login.libproxy.rpi.edu/login?url=https://doi.org/10.1007/s10719-017-9774-7 | |
dc.language | en_US | |
dc.language.iso | ENG | |
dc.relation.ispartof | The Linhardt Research Labs Online Collection | |
dc.relation.ispartof | Rensselaer Polytechnic Institute, Troy, NY | |
dc.relation.ispartof | Glycoconjugate Journal | |
dc.relation.uri | https://harc.rpi.edu/ | |
dc.subject | Biology | |
dc.subject | Chemistry and chemical biology | |
dc.subject | Chemical and biological engineering | |
dc.subject | Biomedical engineering | |
dc.title | Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins | |
dc.type | Article | |
dcterms.accessRights | https://login.libproxy.rpi.edu/login?url=https://doi.org/10.1007/s10719-017-9774-7 | |
dcterms.isPartOf | Journal | |
dcterms.isVersionOf | https://doi.org/10.1007/s10719-017-9774-7 | |
dc.rights.holder | In Copyright : this Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). https://rightsstatements.org/page/InC/1.0/ | |
dc.creator.identifier | https://orcid.org/0000-0003-2219-5833 | |
dc.relation.department | The Linhardt Research Labs. | |
dc.relation.department | The Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) | |
rpi.description.pages | 545-552 | |
rpi.description.volume | 34 | |